- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03350945
Application of Carbon Nanoparticles in Laparoscopic Colorectal Surgery
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Colorectal cancer is among the most commonly diagnosed cancer in both men and women . Increasing studies have been focused on the causes and therapies of this disease in order to improve the prognosis. In recent decades, laparoscopy has been commonly used in both colorectal and gastric surgery due to the benefit of minimal invasive technology progression . Its comparable safety and effectiveness have been proved in many studies. The advantages of minimal invasive surgery such as faster recovery, less bleeding and less pain, have also been admitted by numerous surgeons . However, the accomplishment of operation procedures mainly depend on subjective experiences. Even skilled surgeons can be impeded in operation due to the deficiency of tactile sense . As a result, accurate intra-operative localization of tumor would be a tough task if it was invisible on the serosal surface or difficult to approach, such as small or flat neoplasms, tumor confined to the mucosa and submucosa and endoscopically resected polyps which required additional surgery . At present, three dominant methods can be available to locate tumor: preoperative endoscopic clip placement, intraoperative endoscopy and endoscopic tattooing. All of these methods have their advantages but also some unavoidable limitations, such as localization error and problems in the assessment of incision margin using preoperative clip placement, unsatisfactory operation exposure after intraoperative endoscopy, ink spillage or failure in finding lesions with dye endoscopic injection et al. Usually surgeons choose different methods according to the objective conditions such as the ability to perform endoscopy or the availability of suitable tattooing material.
Apart from the precise localization of tumor, adequate lymph node dissection is another crucial point in colorectal operation. According to AJCC recommendation and NCCN guideline, the number of lymph nodes, which has been proved of prognostic and therapeutic importance, is clearly defined in colorectal cancer to make sure of the accurate pathological staging. Previous studies have found that the number of lymph nodes evaluated after surgical resection was positively associated with the survival of patients. Besides Total Mesorectal Excision (TME) and D3 lymph node clearance, which are standards in colorectal surgery over decades of research and accumulated data, the harvest of lymph nodes is still associated with pathological doctors' experience and pathological examination skills. However, population-based data suggest that lymph node evaluation is not adequate in the majority of patients . Some micro lymph nodes, especially with diameter less than 5 mm, are more easily missed in specimen process while rate of metastasis is comparably higher in these lymph nodes. As a result, clinicians are trying to find a lymph node tracer to help improve the amount of lymph node harvest as well as the rate of micro-metastasis in lymph node.
Carbon nanoparticle has been used as a lymph node tracer for decades. As a lymphatic vessel specific dye material, there is no doubt in its effect on lymph node mapping. In recent years, surgeons have applied this tracer widely in breast and thyroid operations for sentinel lymph node mapping to determine dissection extent. The effectiveness and accuracy of this method has been verified in thyroid and breast surgery while there is rare study focused on its application in colorectal surgery. The application of tattooing material, such as methylene blue, India ink and nano-materials in tumor localization has also attracted attentions of clinicians. In our study, three groups based on different tumor localization means are compared on short-term benefits, cost-effectiveness and lymph node clearance in order to choose the best approach to locate tumor and validate lymph node staining effect of carbon nanoparticles.
Tipo di studio
Iscrizione (Anticipato)
Fase
- Non applicabile
Contatti e Sedi
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Pathologically diagnosed as colorectal benign tumor or tumor with TNM staging I-III (including patients need further surgery after endoscopic treatment), Be able to tolerate laparoscopic radical resection With normal hepatic and renal function No history of abdominal surgery
Exclusion Criteria:
- Patients with distant metastasis, poor compliance, prior abdominal surgery Emergency case with obstruction or perforation Have received neoadjuvant chemotherapy or radiotherapy Patients diagnosed as familial adenomatous polyposis (FAP), Inflammatory bowel disease such as ulcerative colitis and Crohn's disease
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Triplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Device:Titanium Clips
Device: Tumor localization.
Preoperative endoscopic localization with titanium clips
|
At present, three dominant methods can be available to locate tumor: preoperative endoscopic clip placement, intraoperative endoscopy and endoscopic tattooing
|
|
Comparatore attivo: Device:Intra-operative Endoscopy
Device: Tumor localization.
During the laparoscopic surgery,tumor is localized using intra-operative endoscopy detection.
|
At present, three dominant methods can be available to locate tumor: preoperative endoscopic clip placement, intraoperative endoscopy and endoscopic tattooing
|
|
Sperimentale: Device:Carbon Nanoparticles
Device: Tumor localization.
During the laparoscopic surgery,tumor is localized using carbon nanoparticles.
|
At present, three dominant methods can be available to locate tumor: preoperative endoscopic clip placement, intraoperative endoscopy and endoscopic tattooing
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Tumor localization time
Lasso di tempo: within 1 month
|
From abdominal exploration to tumor localization
|
within 1 month
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
survival data 1
Lasso di tempo: within 5 year
|
overall survival
|
within 5 year
|
|
survival data 2
Lasso di tempo: within 5 year
|
disease free survival
|
within 5 year
|
|
Post-operative complication rates
Lasso di tempo: within 6 month
|
According to the records in hospital
|
within 6 month
|
|
Distal edge distance of specimen
Lasso di tempo: within 2 weeks
|
measured by two pathologists separately
|
within 2 weeks
|
|
LN number dissected
Lasso di tempo: within 2-3 weeks
|
measured by two pathologists separately
|
within 2-3 weeks
|
|
Length of stay
Lasso di tempo: within a year
|
According to the record in hospital
|
within a year
|
|
Total operation time
Lasso di tempo: within 1 week
|
Measured according to operation record
|
within 1 week
|
|
Blood loss
Lasso di tempo: within 1 week
|
Measured according to operation record
|
within 1 week
|
Collaboratori e investigatori
Sponsor
Investigatori
- Cattedra di studio: Minhua Zheng, Ruijin Hospital
Studiare le date dei record
Studia le date principali
Inizio studio (Anticipato)
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- LAiguo
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Tumore colorettale
-
University of California, San FranciscoPediatric Neuro-Oncology Consortium; The Lilabean Foundation, Inc.ReclutamentoTumor Ependimale della Fossa Cranica PosterioreStati Uniti
-
Children's Oncology GroupReclutamentoFase I TIPE DI CELLA MISSATO TUMORE KILMS | Stage II TIPI MIXATO TIPO RENO WILMS TUMOR | Stage III TIPI MIXATO TIPO DI RETNO WILMS TUMOR | Stage IV TIPI MIXATO TIPO DI RETNO WILMS TUMORStati Uniti, Canada, Australia
-
RezoluteA disposizioneIperinsulinismo associato a tumore (Tumor HI)
Prove cliniche su Device: tumor localization
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)ReclutamentoNeoplasie ematologiche | Neoplasia solidaStati Uniti
-
University of TorontoUniversity Health Network, TorontoTerminato
-
AGO Study GroupCancer Research UK; ARCAGY/ GINECO GROUP; Grupo Español de Investigación en Cáncer... e altri collaboratoriCompletatoCancro ovarico | Cancro della tuba di Falloppio | Cancro della cavità peritonealeSpagna, Francia, Danimarca, Belgio, Germania, Austria, Cina, Italia, Corea, Repubblica di, Norvegia, Svezia, Regno Unito
-
Tianjin Medical University Second HospitalSconosciuto
-
Dartmouth-Hitchcock Medical CenterReclutamento
-
First Affiliated Hospital Bengbu Medical CollegeReclutamentoAdenocarcinoma dello stomaco | Adenocarcinoma - GEJCina
-
University of Erlangen-Nürnberg Medical SchoolReclutamentoLeucemie linfoblastiche acute (ALL) | Follow-up a lungo termineGermania
-
Li MinNon ancora reclutamento
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinReclutamentoPerdita dell'udito unilaterale | Perdita dell'udito asimmetricaFrancia
-
Thomas Jefferson UniversitySospesoMeningioma ricorrente | Meningioma ad Alto RischioStati Uniti